Abbott spin-off could attract mega merger
October 21, 2011Research and Development, Sales and Marketing Abbott, Bayer, Humira, Merck, Roche
Abbott’s new spin-off pharma firm could attract a lot of attention from big pharma looking to sure up their portfolios. …
UK research cannot rest on its laurels, warns ABPI
October 21, 2011Medical Communications, Research and Development ABPI, NHS, R&D
The ABPI has warned that the UK must continue to attract investment for research, or risk being superseded by emerging …
Abbott to split into two separate companies
October 20, 2011Manufacturing and Production, Research and Development, Sales and Marketing Abbott, Abbott Laboratories
Abbott’s management has decided to split the company into two separate entities in order to give shareholders a ‘distinct investment …
Rumours abound on GSK-HGS takeover bid
October 20, 2011Research and Development, Sales and Marketing Benlysta, GSK, HGS
Rumours are gathering pace that GlaxoSmithKline may launch a takeover bid for struggling US firm Human Genome Sciences. British tabloid …
Injectable Herceptin proves its worth
October 20, 2011Research and Development, Sales and Marketing Herceptin, Roche
An injectable version of Roche’s breast cancer drug Herceptin compares favourably to the standard intravenous infusion, according to new research. …
Medical Devices: Harmonisation of Requirements for Address of Manufacturer
October 19, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
The inclusion of the manufacturer’s address on the labels and instructions for use is an Essential Requirement according to the …
Opportunity to Realise the Value of Dormant UK Authorisations before December Deadline
October 19, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Holders wishing to cancel their authorisations, registrations and licences are required to notify the MHRA by 31 December 2011 to …
GSK malaria vaccine cuts disease risk by half
October 19, 2011Research and Development malaria, malaria vaccine
Results from GSK’s malaria vaccine trial have excited observers after it reduced the risk of the disease by half. Data …
European judge rules against stem cell patents
October 19, 2011Research and Development Stem cells, patents
The European Court of Justice has ruled that stem cells cannot be patented, representing a major blow to research in …
NHS hospital prescribing costs jump
October 19, 2011Sales and Marketing hospital spending, prescribing
New and expensive treatments have driven up NHS prescribing costs in English hospitals, according to a new report. IMS Health …
German biotech Apceth appoints Prof. Ralf Huss
October 19, 2011Research and Development appointment, research and development
Munich-based biotech Apceth has appointed Prof Ralf Huss to its management board. Prof Huss moves to the company from Roche, …
Digital Pharma: It’s not about the brand website
October 19, 2011Sales and Marketing Digital Pharma blog
The last few years have seen an explosion of interest in digital marketing in the pharma sector, reflecting the wider …
Byetta approved for use with insulin
October 19, 2011Amylin, GLP-1, diabetes, lilly
The FDA has approved the use of Lilly and Amylin’s diabetes treatment Byetta as an add-on therapy to insulin glargine.The …
Lundbeck establishes research centre in China
October 18, 2011Research and Development Brain disorders, CNS, China, Lundbeck, Shanghai, emerging markets
Lundbeck has set up a new research centre in China, joining a wave of pharma companies investing in the region. The …
KV Pharma sues ex-chief exec to recoup compensation package
October 18, 2011Ethex, KV Pharma, Marc Hermelin
US drugmaker KV Pharmaceutical is suing its former chief executive Marc Hermelin to avoid paying him a retirement and compensation …
GSK planning job cuts at Quebec vaccines plant
October 18, 2011Manufacturing and Production Canada, GSK, Quebec, vaccines
GlaxoSmithKline has decided to cut around 9% of its workforce in Quebec City, Canada, with a vaccines manufacturing plant bearing …
Angel Bio plans joint venture with Russian drugmaker
October 18, 2011Manufacturing and Production Angel Biotechnology, Materia Medica, Russia, biologics
UK contract manufacturing organisation Angel Biotechnology has agreed to set up a joint venture with Russian counterpart Materia Medica Holding …
NICE recommends Lilly’s long-acting Bydureon
October 18, 2011Sales and Marketing Bydureon, NICE, diabetes
NICE has recommended Eli Lilly’s long-acting diabetes drug Bydureon after the failure of oral treatments. Bydureon (exenatide) – a long-acting …
Grant nominated for key NHS Commissioning Board post
October 18, 2011Commissioning Board, Malcolm Grant, NHS, Nicholson
The government has named its choice for one of the key roles at the new NHS Commissioning Board. Professor Malcolm …
EMA resources stretched by Mediator scandal
October 18, 2011Research and Development, Sales and Marketing EMA, Mediator
The European Medicines Agency has been forced to use ‘considerable resources’ to deal with a flood of enquiries over Mediator …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
